NEW YORK, NY (IANS) – A pharmaceutical company and its Indian American chief have agreed to resolve allegations that they knowingly underpaid Medicaid rebates due for the company’s drug Nitrofurantoin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results